Tech Company Financing Transactions
ImmunoGenetix Therapeutics Funding Round
ImmunoGenetix Therapeutics secured a $100 thousand funding round on 12/31/2010. Investors included Kansas Technology Enterprise Corporation.
Transaction Overview
Company Name
Announced On
12/31/2010
Transaction Type
Venture Equity
Amount
$100,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
8527 Bluejacket St.
Lenexa, KS 66214
USA
Lenexa, KS 66214
USA
Phone
Website
Email Address
Overview
ImmunoGenetix Therapeutics, Inc. is a biotechnology company developing advanced DNA immunotherapies for HIV infection.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Laufenberg
Chief Financial Officer
David Tousley
Browse more venture capital transactions:
Prev: 12/31/2010: Prometheus Energy Group venture capital transaction
Next: 12/31/2010: Accord Biomaterials venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs